NAYA Biosciences Net Income
| NAYADelisted Stock | 2.20 0.18 8.91% |
As of the 17th of February 2026, NAYA Biosciences secures the mean deviation of 5.43, and Standard Deviation of 8.05. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of NAYA Biosciences, as well as the relationship between them.
NAYA Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing NAYA Biosciences' valuation are provided below:NAYA Biosciences does not now have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. NAYA |
Search Suggestions
| NA | Nano Labs | ETF |
| NAK | Northern Dynasty Minerals | Company |
| NAD | Nuveen Dividend Advantage | Fund |
| NAS | NAS | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, NAYA Biosciences reported net income of (8.03 Million). This is 102.35% lower than that of the Healthcare sector and 103.37% lower than that of the Medical Devices industry. The net income for all United States stocks is 101.41% higher than that of the company.
NAYA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NAYA Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NAYA Biosciences could also be used in its relative valuation, which is a method of valuing NAYA Biosciences by comparing valuation metrics of similar companies.NAYA Biosciences is currently under evaluation in net income category among its peers.
NAYA Fundamentals
| Current Valuation | 14.07 M | |||
| Shares Outstanding | 4.48 M | |||
| Shares Owned By Insiders | 15.56 % | |||
| Shares Owned By Institutions | 2.88 % | |||
| Number Of Shares Shorted | 32.45 K | |||
| Price To Book | 5.97 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 3.02 M | |||
| EBITDA | (6.88 M) | |||
| Net Income | (8.03 M) | |||
| Total Debt | 6.3 M | |||
| Book Value Per Share | (3.91) X | |||
| Cash Flow From Operations | (4.76 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (1.01) X | |||
| Target Price | 2.0 | |||
| Market Capitalization | 2.48 M | |||
| Total Asset | 18.51 M | |||
| Retained Earnings | (57.82 M) | |||
| Working Capital | (6.74 M) | |||
| Net Asset | 18.51 M |
About NAYA Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NAYA Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NAYA Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NAYA Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in NAYA Stock
If you are still planning to invest in NAYA Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NAYA Biosciences' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |